Lyciar-15a is an innovative phytotherapeutic preparation, derived from wild desert plants of the Arabian region, specifically designed to support patients suffering from advanced malignant conditions. The formula is intended for a broad range of indications, including malignancies of the throat, thyroid, skin, bones, urinary bladder, sarcomas, as well as other rare and aggressive pathologies.*
The therapeutic effects of Lyciar-15a are attributed to the broad biological activity of its bioactive secondary metabolites:
The formula contains more than 180 phytochemical compounds, including:
This phytocomplex establishes a unique pharmacological profile, combining antitumoral, immunostimulant, and hepatoprotective effects.